Search for a report

GERMANY MULTIPLEX ASSAY MARKET FORECAST 2021-2026

  • You are here:
  • Home
  • Downloads
  • GERMANY MULTIPLEX ASSAY MARKET FORECAST 2021-2026

GERMANY MULTIPLEX ASSAY MARKET FORECAST 2021-2026

The Germany multiplex assay market is forecasting to record a CAGR of 8.90% during the estimated years. The market growth of the country is mainly ascribed to the developments within the pharmaceutical industry, in addition to the collaborations and partnerships of clinical trials. While the base year considered for the market study is 2020, the forecasted period is from 2021 to 2026.

GERMANY MULTIPLEX ASSAY MARKET FORECAST 2021-2026

Germany Multiplex Assay Market by Type ( Protein-based Multiplex Assay, Nucleic Acid-based Multiplex Assay, Other Multiplex Assays ) Market by Product ( Reagents and Consumables, Instruments and Accessories, Software and Services ) Market by Technology ( Multiplex Protein Microarray, Multiplex Pcr, Other Technologies ) Market by Application ( Clinical Diagnostics, Research and Development, Companion Diagnostics ) Market by End-user ( Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies )

Request free sample

The Germany multiplex assay market is estimated to record a CAGR of 8.90% during the forecasting years. The market growth of the country is mainly ascribed to the developments within the pharmaceutical industry, in addition to the collaborations and partnerships of clinical trials. While the base year considered for the market study is 2020, the forecasted period is from 2021 to 2026.germany-multiplex-assay-market

To learn more about this report, request a free sample copy

The multiplex assay market observes substantial growth on account of increased research and development activities in pharmaceuticals for treating numerous diseases. Furthermore, the assays are utilized in clinical trials since they reduce the expenditure on manual labor and research and enhance the efficacy of treatments and therapies. Hence, the development of the pharmaceutical industry in Germany is anticipated to offer lucrative growth opportunities to the country’s multiplex assay market.

On the other hand, multiplex assay technology is set to help pharmaceutical companies in reducing the cost of clinical trials by minimizing approval time and drug development expenses. In this regard, as per the Association of Research-Based Pharmaceutical Companies, 17 out of 42 member companies within the German Association of Research-Based Pharmaceutical Companies operate laboratories in Germany. Therefore, these factors are anticipated to facilitate the country’s market for multiplex assay during the forecasting period.

Siemens Healthineers AG, headquartered in Germany, is the parent company for numerous medical technology firms. Connected to the larger corporation, Siemens AG, the company’s business operations were rebranded ‘Siemens Healthineers’ in May 2016. Its business line includes the production of surgical, medical, ophthalmic, and veterinary instruments and apparatus, with full-spectrum imaging, advanced therapies, diagnostics, and services. Moreover, Siemens is the market leader in imaging systems and has also pioneered designs of computed tomography (CT), molecular imaging, and others.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYER’S POWER
        • SUPPLIER’S POWER
        • COMPETITIVE RIVALRY
      • IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    4. MARKET BY TYPE
      • PROTEIN-BASED MULTIPLEX ASSAY
      • NUCLEIC ACID-BASED MULTIPLEX ASSAY
      • OTHER MULTIPLEX ASSAYS
    5. MARKET BY PRODUCT
      • REAGENTS AND CONSUMABLES
      • INSTRUMENTS AND ACCESSORIES
      • SOFTWARE AND SERVICES
    6. MARKET BY TECHNOLOGY
      • MULTIPLEX PROTEIN MICROARRAY
      • MULTIPLEX PCR
      • OTHER TECHNOLOGIES
    7. MARKET BY APPLICATION
      • CLINICAL DIAGNOSTICS
      • RESEARCH AND DEVELOPMENT
      • COMPANION DIAGNOSTICS
    8. MARKET BY END-USER
      • HOSPITALS
      • CLINICAL LABORATORIES
      • RESEARCH INSTITUTES
      • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    9. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
        • BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
      • COMPANY PROFILES
        • AGILENT TECHNOLOGIES INC
        • HOFFMANN-LA ROCHE
        • QIAGEN NV
        • RANDOX LABORATORIES LTD
        • SIEMENS HEALTHINEERS AG

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – MULTIPLEX ASSAY

    TABLE 2: GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 4: GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 6: GERMANY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: GERMANY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 8: GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 10: GERMANY MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: GERMANY MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 12: LIST OF MERGERS & ACQUISITIONS

    TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 14: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

    TABLE 15: LIST OF BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS

    LIST OF FIGURES 

    FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020

    FIGURE 5: GERMANY MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2026 (IN $ MILLION)

    FIGURE 6: GERMANY MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2026 (IN $ MILLION)

    FIGURE 7: GERMANY MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2026 (IN $ MILLION)

    FIGURE 8: GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020

    FIGURE 9: GERMANY MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2026 (IN $ MILLION)

    FIGURE 10: GERMANY MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2026 (IN $ MILLION)

    FIGURE 11: GERMANY MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2026 (IN $ MILLION)

    FIGURE 12: GERMANY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 13: GERMANY MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2026 (IN $ MILLION)

    FIGURE 14: GERMANY MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2026 (IN $ MILLION)

    FIGURE 15: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)

    FIGURE 16: GERMANY MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2026 (IN $ MILLION)

    FIGURE 17: GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020

    FIGURE 18: GERMANY MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2026 (IN $ MILLION)

    FIGURE 19: GERMANY MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2026 (IN $ MILLION)

    FIGURE 20: GERMANY MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2026 (IN $ MILLION)

    FIGURE 21: GERMANY MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020

    FIGURE 22: GERMANY MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2026 (IN $ MILLION)

    FIGURE 23: GERMANY MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2026 (IN $ MILLION)

    FIGURE 24: GERMANY MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2026 (IN $ MILLION)

    FIGURE 25: GERMANY MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2026 (IN $ MILLION)

    1. MARKET BY TYPE
      • PROTEIN-BASED MULTIPLEX ASSAY
      • NUCLEIC ACID-BASED MULTIPLEX ASSAY
      • OTHER MULTIPLEX ASSAYS
    2. MARKET BY PRODUCT
      • REAGENTS AND CONSUMABLES
      • INSTRUMENTS AND ACCESSORIES
      • SOFTWARE AND SERVICES
    3. MARKET BY TECHNOLOGY
      • MULTIPLEX PROTEIN MICROARRAY
      • MULTIPLEX PCR
      • OTHER TECHNOLOGIES
    4. MARKET BY APPLICATION
      • CLINICAL DIAGNOSTICS
      • RESEARCH AND DEVELOPMENT
      • COMPANION DIAGNOSTICS
    5. MARKET BY END-USER
      • HOSPITALS
      • CLINICAL LABORATORIES
      • RESEARCH INSTITUTES
      • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now